George Washington launches legal website on health data

Beth Walsh | | Health Exec | Economics
Physicians & Smartphones - 26.17 Kb
George Washington University’s Hirsh Health Law and Policy Program in Washington, D.C., has launched an online resource, Health Information and the Law.

The website, HealthInfoLaw.org, developed with support from the Robert Wood Johnson Foundation, is an online guide to federal and state laws governing access, use, release and publication of health information.

According to information published on the university's website, the staff intends the site to be of use to a variety of audiences and will continue to build the resource, "adding depth to the research content as well as expert analyses of emerging legal issues that arise as health information is increasingly used to support provider performance measurement and improvement, public reporting, evidence-based research and payment and delivery reform."

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.